These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
170 related items for PubMed ID: 35025908
1. Implants for HIV prevention in young women: Provider perceptions and lessons learned from contraceptive implant provision. Humphries H, Upfold M, Mahlase G, Mdladla M, Gengiah TN, Abdool Karim Q. PLoS One; 2022; 17(1):e0262043. PubMed ID: 35025908 [Abstract] [Full Text] [Related]
2. Design of an Implant for Long-Acting HIV Pre-Exposure Prophylaxis: Input from South African Health Care Providers. Krogstad EA, Montgomery ET, Atujuna M, Minnis AM, O'Rourke S, Ahmed K, Bekker LG, van der Straten A. AIDS Patient Care STDS; 2019 Apr; 33(4):157-166. PubMed ID: 30932697 [Abstract] [Full Text] [Related]
3. Understanding the Acceptability of Subdermal Implants as a Possible New HIV Prevention Method: Multi-Stage Mixed Methods Study. Rael CT, Lentz C, Carballo-Diéguez A, Giguere R, Dolezal C, Feller D, D'Aquila RT, Hope TJ. J Med Internet Res; 2020 Jul 27; 22(7):e16904. PubMed ID: 32348277 [Abstract] [Full Text] [Related]
4. Epidemiological impact and cost-effectiveness of providing long-acting pre-exposure prophylaxis to injectable contraceptive users for HIV prevention in South Africa: a modelling study. van Vliet MM, Hendrickson C, Nichols BE, Boucher CA, Peters RP, van de Vijver DA. J Int AIDS Soc; 2019 Dec 27; 22(12):e25427. PubMed ID: 31855323 [Abstract] [Full Text] [Related]
6. Client experiences with "Dynamic Choice Prevention," a model for flexible patient-centred HIV prevention delivery in rural Eastern Africa. Camlin CS, Arunga T, Johnson-Peretz J, Akatukwasa C, Atwine F, Onyango A, Owino L, Kamya MR, Petersen ML, Chamie G, Kakande E, Kabami J, Balzer LB, Havlir DV, Ayieko J. J Int AIDS Soc; 2024 Jul 27; 27(7):e26336. PubMed ID: 39020454 [Abstract] [Full Text] [Related]
7. Perspectives on contraceptive implant use in women living with HIV in Cape Town, South Africa: a qualitative study among primary healthcare providers and stakeholders. Brown A, Harries J, Cooper D, Morroni C. BMC Public Health; 2019 Jul 26; 19(1):1003. PubMed ID: 31349786 [Abstract] [Full Text] [Related]
10. Exploring user and stakeholder perspectives from South Africa and Uganda to refine microarray patch development for HIV PrEP delivery and as a multipurpose prevention technology. Ismail A, Magni S, Katahoire A, Ayebare F, Siu G, Semitala F, Kyambadde P, Friedland B, Jarrahian C, Kilbourne-Brook M. PLoS One; 2023 Jul 26; 18(8):e0290568. PubMed ID: 37651432 [Abstract] [Full Text] [Related]
19. Influences of geo-spatial location on pre-exposure prophylaxis use in South Africa: positioning microbicides for better product uptake. Govender EM, Mansoor LE, Abdool Karim Q. AIDS Care; 2017 Jun 26; 29(6):734-740. PubMed ID: 27799005 [Abstract] [Full Text] [Related]
20. The cost-effectiveness of multi-purpose HIV and pregnancy prevention technologies in South Africa. Quaife M, Terris-Prestholt F, Eakle R, Cabrera Escobar MA, Kilbourne-Brook M, Mvundura M, Meyer-Rath G, Delany-Moretlwe S, Vickerman P. J Int AIDS Soc; 2018 Mar 26; 21(3):. PubMed ID: 29537654 [Abstract] [Full Text] [Related] Page: [Next] [New Search]